2006-000336-28: A 52-week open-label, single-arm, multi-center study to evaluate the long term safety of pimecrolimus 1% cream intermittent treatment of seborrhoeic dermatitis in patients 12 years of age and older |
|
|
| Ongoing | 4 | 544 | Europe | Elidel Cream 1%, Cream, Elidel, creme | Novartis Pharma Services AG | Seborrhoeic dermatitis (SD) | | | | |
2005-003644-59: A two months study of the utility of Elidel cream 1% (pimecrolimus) in the long term management of atopic hand eczema. |
|
|
| Ongoing | 4 | 40 | Europe | Elidel 1% Creme, Elidel 1% Creme, Elidel 1% Creme | University of Heidelberg | chronically relapsing atopic hand eczema | | | | |
ChiCTR2200060584: A randomized controlled study comparing the efficacy and safety of 2% Crisaborole ointment versus 1% Pimemollimus cream in the treatment of mild to moderate atopic dermatitis in children aged 2 years and older |
|
|
| Recruiting | 4 | 120 | | Topical use of Crisaborole, twice a day ;Topical use of Pimecrolimus, twice a day | Shenzhen Children's Hospital; Shenzhen Children's Hospital, Chinese National Health Association | Atopic dermatitis | | | | |
